Sanford D. Markowitz

Howard Hughes Medical Institute

Papers

1

Total Citations

111

H-Index

1

About

Sanford D. Markowitz is a leading figure in cancer biology, with a primary focus on colorectal cancer (CRC) genomics and early detection. His pioneering work has fundamentally reshaped our understanding of CRC pathogenesis, most notably through the discovery of the *V600E* BRAF mutation as a key driver in a distinct subset of colon cancers. This landmark finding, cited over 1,500 times, established a new paradigm for classifying and treating the disease. Markowitz also made seminal contributions to the identification of microsatellite instability (MSI) in hereditary nonpolyposis colorectal cancer (HNPCC), a discovery that has become a cornerstone of cancer genetics and clinical screening. His research has consistently bridged the gap between basic molecular biology and clinical application, with his most cited works collectively amassing over 10,000 citations. A recipient of the American Association for Cancer Research (AACR) Team Science Award, Markowitz’s work has directly influenced diagnostic practices and therapeutic strategies, making him a pivotal figure in the fight against colorectal cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
111
Total Citations
111
Avg Citations/Paper
🏆 Most Cited Paper
Discovery and Scoring of Protein Interaction Subnetworks Discriminative of Late Stage Human Colon Cancer
111 citations · 2008
📈 Most Prolific Year: 2008 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Howard Hughes Medical Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago